Actively Recruiting
A Study of ORN252 in Healthy Participants
Led by Orna Therapeutics, Inc. · Updated on 2026-04-16
20
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the safety and tolerability of ORN252 in healthy adult participants.
CONDITIONS
Official Title
A Study of ORN252 in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female participants who are healthy as determined by the Investigator based on review of medical history, physical examination, and laboratory tests
- Participant is willing and able to comply with study visits and other protocol requirements
- Other protocol specific inclusion criteria may apply
You will not qualify if you...
- Clinically significant history or presence of organ dysfunction
- Use of any investigational product within 3 months, or 5 half-lives, whichever longer
- Other protocol specific exclusion criteria may apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nucleus Network
Herston, Queensland, Australia, 4006
Actively Recruiting
Research Team
O
Orna Clinical Trials
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here